Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.92 is 63% above its 5-year average of -5.26, near the high end of its 5-year range (-20.40–-0.84).
82.47% above its 12-month average of -10.95.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.55.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.92
EARNINGS PER SHARE (EPS) AVG TTM
-10.95
EARNINGS PER SHARE (EPS) AVG 3Y
-6.49
EARNINGS PER SHARE (EPS) AVG 5Y
-5.26
EARNINGS PER SHARE (EPS) AVG 10Y
-4.28
EARNINGS PER SHARE (EPS) AVG 15Y
-2.94
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+82.47%
CURRENT VS 3Y AVG
+70.39%
CURRENT VS 5Y AVG
+63.48%
CURRENT VS 10Y AVG
+55.13%
CURRENT VS 15Y AVG
+34.72%
CURRENT VS 20Y AVG
N/A
Satellos Bioscience Inc.
Market Cap
$10.42M
Earnings Per Share (EPS)
-1.92
TTM Avg
-10.95
3Y Avg
-6.49
5Y Avg
-5.26
Market Cap
$10.33M
Earnings Per Share (EPS)
-1.77
TTM Avg
-11.49
3Y Avg
-12.47
5Y Avg
-11.51
Market Cap
$10.51M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$10.32M
Earnings Per Share (EPS)
N/A
TTM Avg
-68.10
3Y Avg
-34.05
5Y Avg
-22.70
Market Cap
$10.65M
Earnings Per Share (EPS)
-1.64
TTM Avg
-2.15
3Y Avg
-4.34
5Y Avg
-5.45
Market Cap
$10.06M
Earnings Per Share (EPS)
-1.62
TTM Avg
-1.32
3Y Avg
-0.82
5Y Avg
-0.71
Market Cap
$9.92M
Earnings Per Share (EPS)
-16.82
TTM Avg
-28.56
3Y Avg
-28.65
5Y Avg
-34.30
Market Cap
$10.94M
Earnings Per Share (EPS)
-4.43
TTM Avg
-27.97
3Y Avg
-98701.49
5Y Avg
-256134.32
Market Cap
$10.96M
Earnings Per Share (EPS)
-0.73
TTM Avg
-0.46
3Y Avg
-0.46
5Y Avg
-0.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Satellos Bioscience Inc. (MSLE) | $10.42M | -1.92 | -10.95 | -6.49 | -5.26 |
| Senti Biosciences, Inc. (SNTI)vs › | $10.33M | -1.77 | -11.49 | -12.47 | -11.51 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -0.21 | -0.25 | -0.25 |
| Polyrizon Ltd. (PLRZ)vs › | $10.32M | N/A | -68.10 | -34.05 | -22.70 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | -1.64 | -2.15 | -4.34 | -5.45 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -1.62 | -1.32 | -0.82 | -0.71 |
| Lifeward Ltd. (LFWD)vs › | $9.92M | -16.82 | -28.56 | -28.65 | -34.30 |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -4.43 | -27.97 | -98701.49 | -256134.32 |
| Caring Brands, Inc. (CABR)vs › | $10.96M | -0.73 | -0.46 | -0.46 | -0.46 |
| MetaVia Inc. (MTVA)vs › | $9.88M | -4.07 | -23.25 | -137.85 | -1187.50 |
Trailing EPS (TTM)
$-1.92
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -20.40 |
| 2024-12-31 | -1.50 |
| 2023-12-31 | -1.23 |
| 2022-12-31 | -2.81 |
| 2021-12-31 | -4.76 |
| 2020-12-31 | -0.84 |
| 2019-12-31 | -3.00 |
| 2018-12-31 | -3.53 |
| 2017-12-31 | -1.94 |
| 2016-12-31 | -3.60 |
| 2015-12-31 | -3.46 |
| 2014-12-31 | -3.94 |
| 2013-12-31 | -19.29 |
| 2012-12-31 | -16.96 |
| 2011-12-31 | -4.69 |
| 2010-12-31 | -19.33 |
| 2009-12-31 | -18.23 |
| 2008-12-31 | -24.03 |
| 2007-12-31 | -274.63 |
